Outcomes | Weighted % (crude frequency: ‘yes’/total)* | OR | 95% CI | P value |
Primary outcome | ||||
Wheezing in chest | 13.04 (537/4388) | 1.18 | 1.02 to 1.36 | 0.03 |
Secondary outcomes | ||||
At least one sleep disturbance due to wheezing | 7.04 (304/4388) | 1.26 | 1.05 to 1.51 | 0.01 |
Wheezing during exercise | 6.91 (292/4385) | 1.34 | 1.08 to 1.67 | 0.007 |
At least one doctor, hospital or emergency room visit for wheezing | 8.17 (325/4388) | 1.05 | 0.87 to 1.27 | 0.64 |
Wheezing requiring prescription medication use | 9.45 (399/4388) | 1.35 | 1.13 to 1.63 | 0.001 |
Limitation of usual activities due to wheezing | 5.39 (229/4388) | 1.20 | 0.98 to 1.47 | 0.08 |
At least 1 day of school or work missed due to wheezing | 4.31 (169/4245) | 1.12 | 0.90 to 1.40 | 0.34 |
Dry nocturnal cough | 2.63 (124/4386) | 1.15 | 0.83 to 1.61 | 0.41 |
*Survey procedures were used to account for the NHANES survey design and to obtain population weighted estimates for prevalence and OR estimates. OR estimates were based on logistic models adjusted for age, sex, race/ethnicity, poverty to family income ratio, body mass index percentile, current asthma and total Healthy Eating Index score.
AGE, advanced glycation end product; NHANES, National Health and Nutrition Examination Survey.